{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T23:00:27Z","timestamp":1783551627808,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T00:00:00Z","timestamp":1382659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2369-14-232","type":"journal-article","created":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T04:53:17Z","timestamp":1382676797000},"source":"Crossref","is-referenced-by-count":38,"title":["Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid\u2013base status and phosphate supplementation needs"],"prefix":"10.1186","volume":"14","author":[{"given":"Santo","family":"Morabito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Pistolesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Tritapepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Vitaliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Zeppilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Polistena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Fiaccadori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pierucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,25]]},"reference":[{"key":"654_CR1","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s00134-007-0754-4","volume":"33","author":"S Uchino","year":"2007","unstructured":"Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten H, Ronco C, Kellum JA: Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med. 2007, 33: 1563-1570. 10.1007\/s00134-007-0754-4.","journal-title":"Intensive Care Med"},{"key":"654_CR2","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2215\/CJN.00430107","volume":"2","author":"C Ronco","year":"2007","unstructured":"Ronco C, Bellomo R: Dialysis in intensive care unit patients with acute kidney injury: continuous therapy is superior. Clin J Am Soc Nephrol. 2007, 2: 597-600. 10.2215\/CJN.00430107.","journal-title":"Clin J Am Soc Nephrol"},{"key":"654_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00134-012-2706-x","volume":"39","author":"M Legrand","year":"2013","unstructured":"Legrand M, Darmon M, Joannidis M, Payen D: Management of renal replacement therapy in ICU patients: an international survey. Intensive Care Med. 2013, 39: 101-108. 10.1007\/s00134-012-2706-x.","journal-title":"Intensive Care Med"},{"key":"654_CR4","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1097\/00002480-199410000-00005","volume":"40","author":"RL Mehta","year":"1994","unstructured":"Mehta RL: Anticoagulation during continuous renal replacement therapies. ASAIO J. 1994, 40: 931-935.","journal-title":"ASAIO J"},{"key":"654_CR5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1681\/ASN.V71145","volume":"7","author":"J Van de Wetering","year":"1996","unstructured":"Van de Wetering J, Westendorp RG, van der Hoeven JG, Stolk B, Feuth JD, Chang PC: Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol. 1996, 7: 145-150.","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl","key":"654_CR6","first-page":"1","volume":"2","author":"Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","unstructured":"Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO clinical practice guideline for acute kidney injury. Kidney Int. 2012, 2 (Suppl): 1-138.","journal-title":"Kidney Int"},{"key":"654_CR7","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1046\/j.1523-1755.2001.0590041510.x","volume":"59","author":"E Fiaccadori","year":"2001","unstructured":"Fiaccadori E, Maggiore U, Clima B, Melfa L, Rotelli C, Borghetti A: Incidence, risk factors, and prognosis of gastrointestinal hemorrhage complicating acute renal failure. Kidney Int. 2001, 59: 1510-1519. 10.1046\/j.1523-1755.2001.0590041510.x.","journal-title":"Kidney Int"},{"key":"654_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/ndtplus\/sfp136","volume":"2","author":"A Davenport","year":"2009","unstructured":"Davenport A, Tolwani A: Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit. NDT Plus. 2009, 2: 439-447. 10.1093\/ndtplus\/sfp136.","journal-title":"NDT Plus"},{"key":"654_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/cc9358","volume":"15","author":"HM Oudemans-van Straaten","year":"2011","unstructured":"Oudemans-van Straaten HM, Kellum JA, Bellomo R: Clinical review: anticoagulation for continuous renal replacement therapy\u2013heparin or citrate?. Crit Care. 2011, 15: 202-","journal-title":"Crit Care"},{"key":"654_CR10","first-page":"14","volume":"29","author":"S Morabito","year":"2012","unstructured":"Morabito S, Pistolesi V, Pierucci A: Regional citrate anticoagulation: towards a first-choice treatment. G Ital Nefrol. 2012, 29: 14-19.","journal-title":"G Ital Nefrol"},{"key":"654_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00134-011-2438-3","volume":"38","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Hongying N: Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive Care Med. 2012, 38: 20-28. 10.1007\/s00134-011-2438-3.","journal-title":"Intensive Care Med"},{"key":"654_CR12","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1053\/j.ajkd.2011.11.030","volume":"59","author":"MY Wu","year":"2012","unstructured":"Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, Tam KW: Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2012, 59: 810-818. 10.1053\/j.ajkd.2011.11.030.","journal-title":"Am J Kidney Dis"},{"key":"654_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/cc11645","volume":"16","author":"HM Oudemans-van Straaten","year":"2012","unstructured":"Oudemans-van Straaten HM, Ostermann M: Bench-to-bedside review: citrate for continuous renal replacement therapy, from science to practice. Crit Care. 2012, 16: 249-10.1186\/cc11645.","journal-title":"Crit Care"},{"key":"654_CR14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s00134-003-2047-x","volume":"30","author":"M Monchi","year":"2004","unstructured":"Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P: Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med. 2004, 30: 260-265. 10.1007\/s00134-003-2047-x.","journal-title":"Intensive Care Med"},{"key":"654_CR15","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1111\/j.1523-1755.2005.00342.x","volume":"67","author":"DJ Kutsogiannis","year":"2005","unstructured":"Kutsogiannis DJ, Gibney RT, Stollery D, Gao J: Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int. 2005, 67: 2361-2367. 10.1111\/j.1523-1755.2005.00342.x.","journal-title":"Kidney Int"},{"key":"654_CR16","first-page":"602","volume":"20","author":"MG Betjes","year":"2007","unstructured":"Betjes MG, van Oosterom D, van Agteren M, van de Wetering J: Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding. J Nephrol. 2007, 20: 602-608.","journal-title":"J Nephrol"},{"key":"654_CR17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/CCM.0b013e3181953c5e","volume":"37","author":"HM Oudemans-van Straaten","year":"2009","unstructured":"Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI, Dijksman LM, Zandstra DF: Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med. 2009, 37: 545-552. 10.1097\/CCM.0b013e3181953c5e.","journal-title":"Crit Care Med"},{"key":"654_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/ndt\/gfq575","volume":"26","author":"GR Hetzel","year":"2011","unstructured":"Hetzel GR, Schmitz M, Wissing H, Ries W, Schott G, Heering PJ, Isgro F, Kribben A, Himmele R, Grabensee B, Rump LC: Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant. 2011, 26: 232-239. 10.1093\/ndt\/gfq575.","journal-title":"Nephrol Dial Transplant"},{"key":"654_CR19","doi-asserted-by":"publisher","first-page":"R111","DOI":"10.1186\/cc11403","volume":"16","author":"S Morabito","year":"2012","unstructured":"Morabito S, Pistolesi V, Tritapepe L, Zeppilli L, Polistena F, Strampelli E, Pierucci A: Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution. Crit Care. 2012, 16: R111-10.1186\/cc11403.","journal-title":"Crit Care"},{"key":"654_CR20","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/00041552-199911000-00009","volume":"8","author":"S Abramson","year":"1999","unstructured":"Abramson S, Niles JL: Anticoagulation in continuous renal replacement therapy. Curr Opin Nephrol Hypertens. 1999, 8: 701-707. 10.1097\/00041552-199911000-00009.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"654_CR21","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1093\/ndt\/gfr106","volume":"26","author":"F Mariano","year":"2011","unstructured":"Mariano F, Morselli M, Bergamo D, Hollo Z, Scella S, Maio M, Tetta C, Dellavalle A, Stella M, Triolo G: Blood and ultrafiltrate dosage of citrate as a useful and routine tool during continuous venovenous haemodiafiltration in septic shock patients. Nephrol Dial Transplant. 2011, 26: 3882-3888. 10.1093\/ndt\/gfr106.","journal-title":"Nephrol Dial Transplant"},{"key":"654_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2215\/CJN.00040505","volume":"1","author":"AJ Tolwani","year":"2006","unstructured":"Tolwani AJ, Prendergast MB, Speer RR, Stofan BS, Wille KM: A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance. Clin J Am Soc Nephrol. 2006, 1: 79-87.","journal-title":"Clin J Am Soc Nephrol"},{"key":"654_CR23","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1097\/CCM.0b013e3181a00a92","volume":"37","author":"S Morgera","year":"2009","unstructured":"Morgera S, Schneider M, Slowinski T, Vargas-Hein O, Zuckermann-Becker H, Peters H, Kindgen-Milles D, Neumayer HH: A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid\u2013base status. Crit Care Med. 2009, 37: 2018-2024. 10.1097\/CCM.0b013e3181a00a92.","journal-title":"Crit Care Med"},{"key":"654_CR24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1542-4758.2012.00730.x","volume":"17","author":"S Morabito","year":"2013","unstructured":"Morabito S, Pistolesi V, Tritapepe L, Zeppilli L, Polistena F, Fiaccadori E, Pierucci A: Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid. Hemodial Int. 2013, 17: 313-320. 10.1111\/j.1542-4758.2012.00730.x.","journal-title":"Hemodial Int"},{"key":"654_CR25","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1007\/s00134-004-2333-2","volume":"30","author":"S Troyanov","year":"2004","unstructured":"Troyanov S, Geadah D, Ghannoum M, Cardinal J, Leblanc M: Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy. Intensive Care Med. 2004, 30: 1662-1665.","journal-title":"Intensive Care Med"},{"key":"654_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/NEJMoa0802639","volume":"359","author":"PM Palevsky","year":"2008","unstructured":"Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P, VA\/NIH Acute Renal Failure Trial Network: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008, 359: 7-20.","journal-title":"N Engl J Med"},{"key":"654_CR27","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa0902413","volume":"361","author":"R Bellomo","year":"2009","unstructured":"Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S, RENAL Replacement Therapy Study Investigators: Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009, 361: 1627-1638.","journal-title":"N Engl J Med"},{"key":"654_CR28","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/ki.2008.570","volume":"75","author":"MJ Santiago","year":"2009","unstructured":"Santiago MJ, L\u00f3pez-Herce J, Urbano J, Bell\u00f3n JM, del Castillo J, Carrillo A: Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children. Kidney Int. 2009, 75: 312-316. 10.1038\/ki.2008.570.","journal-title":"Kidney Int"},{"key":"654_CR29","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1093\/ndt\/gfr075","volume":"26","author":"S Demirjian","year":"2011","unstructured":"Demirjian S, Teo BW, Guzman JA, Heyka RJ, Paganini EP, Fissell WH, Schold JD, Schreiber MJ: Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant. 2011, 26: 3508-3514. 10.1093\/ndt\/gfr075.","journal-title":"Nephrol Dial Transplant"},{"key":"654_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1399-6576.2010.02338.x","volume":"55","author":"M Broman","year":"2011","unstructured":"Broman M, Carlsson O, Friberg H, Wieslander A, Godaly G: Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy. Acta Anaesthesiol Scand. 2011, 55: 39-45. 10.1111\/j.1399-6576.2010.02338.x.","journal-title":"Acta Anaesthesiol Scand"},{"key":"654_CR31","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1159\/000345343","volume":"34","author":"HR Chua","year":"2012","unstructured":"Chua HR, Baldwin I, Ho L, Collins A, Allsep H, Bellomo R: Biochemical effects of phosphate-containing replacement fluid for continuous venovenous hemofiltration. Blood Purif. 2012, 34: 306-312. 10.1159\/000345343.","journal-title":"Blood Purif"},{"key":"654_CR32","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/0049-3848(81)90270-X","volume":"21","author":"LR Whitfield","year":"1981","unstructured":"Whitfield LR, Levy G: Permeability of human and rat red blood cells to citrate. Thromb Res. 1981, 21: 681-684. 10.1016\/0049-3848(81)90270-X.","journal-title":"Thromb Res"},{"key":"654_CR33","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1093\/ndt\/gfp017","volume":"24","author":"J Kozik-Jaromin","year":"2009","unstructured":"Kozik-Jaromin J, Nier V, Heemann U, Kreymann B, Bohler J: Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation. Nephrol Dial Transplant. 2009, 24: 2244-2251. 10.1093\/ndt\/gfp017.","journal-title":"Nephrol Dial Transplant"},{"key":"654_CR34","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1053\/j.ajkd.2006.07.016","volume":"48","author":"GR Hetzel","year":"2006","unstructured":"Hetzel GR, Taskaya G, Sucker C, Hennersdorf M, Grabensee B, Schmitz M: Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration. Am J Kidney Dis. 2006, 48: 806-811. 10.1053\/j.ajkd.2006.07.016.","journal-title":"Am J Kidney Dis"},{"key":"654_CR35","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00134-010-1909-2","volume":"36","author":"F Mariano","year":"2010","unstructured":"Mariano F, Tedeschi L, Morselli M, Stella M, Triolo G: Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients. Intensive Care Med. 2010, 36: 1735-1743. 10.1007\/s00134-010-1909-2.","journal-title":"Intensive Care Med"},{"key":"654_CR36","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1515\/CCLM.2006.164","volume":"44","author":"AJ Bakker","year":"2006","unstructured":"Bakker AJ, Boerma EC, Keidel H, Kingma P, van der Voort PH: Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total\/ionised calcium. Clin Chem Lab Med. 2006, 44: 962-966.","journal-title":"Clin Chem Lab Med"},{"key":"654_CR37","doi-asserted-by":"publisher","first-page":"R162","DOI":"10.1186\/cc11485","volume":"16","author":"C Schulthei\u00df","year":"2012","unstructured":"Schulthei\u00df C, Saugel B, Phillip V, Thies P, Noe S, Mayr U, Haller B, Einwachter H, Schmid RM, Huber W: Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study. Crit Care. 2012, 16: R162-10.1186\/cc11485.","journal-title":"Crit Care"},{"key":"654_CR38","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/cc11363","volume":"16","author":"A Link","year":"2012","unstructured":"Link A, Klingele M, Speer T, Rbah R, Poss J, Lerner-Graber A, Fliser D, Bohm M: Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients. Crit Care. 2012, 16: R97-10.1186\/cc11363.","journal-title":"Crit Care"},{"key":"654_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1744-9987.2011.01001.x","volume":"16","author":"HP Shum","year":"2012","unstructured":"Shum HP, Chan KC, Yan WW: Regional citrate anticoagulation in predilution continuous venovenous hemofiltration using prismocitrate 10\/2 solution. Ther Apher Dial. 2012, 16: 81-86. 10.1111\/j.1744-9987.2011.01001.x.","journal-title":"Ther Apher Dial"},{"key":"654_CR40","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jcrc.2009.02.013","volume":"25","author":"J Aman","year":"2010","unstructured":"Aman J, Nurmohamed SA, Vervloet MG, Groeneveld AB: Metabolic effects of citrate- vs bicarbonate-based substitution fluid in continuous venovenous hemofiltration: a prospective sequential cohort study. J Crit Care. 2010, 25: 120-127. 10.1016\/j.jcrc.2009.02.013.","journal-title":"J Crit Care"},{"key":"654_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1471-2369-14-89","volume":"14","author":"SA Nurmohamed","year":"2013","unstructured":"Nurmohamed SA, Jallah BP, Vervloet MG, Yldirim G, ter Wee PM, Groeneveld AB: Continuous venovenous haemofiltration with citrate-buffered replacement solution is safe and efficacious in patients with a bleeding tendency: a prospective observational study. BMC Nephrol. 2013, 14: 89-10.1186\/1471-2369-14-89.","journal-title":"BMC Nephrol"},{"key":"654_CR42","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1053\/j.jrn.2013.01.025","volume":"23","author":"E Fiaccadori","year":"2013","unstructured":"Fiaccadori E, Maggiore U, Cabassi A, Morabito S, Castellano G, Regolisti G: Nutritional evaluation and management of AKI patients. J Ren Nutr. 2013, 23: 255-258. 10.1053\/j.jrn.2013.01.025.","journal-title":"J Ren Nutr"},{"key":"654_CR43","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jcrc.2013.03.010","volume":"28","author":"S Suzuki","year":"2013","unstructured":"Suzuki S, Egi M, Schneider AG, Bellomo R, Hart GK, Hegarty C: Hypophosphatemia in critically ill patients. J Crit Care. 2013, 28: 536-","journal-title":"J Crit Care"},{"key":"654_CR44","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1046\/j.1365-2044.1998.00463.x","volume":"53","author":"NC Bugg","year":"1998","unstructured":"Bugg NC, Jones JA: Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit. Anaesthesia. 1998, 53: 895-902. 10.1046\/j.1365-2044.1998.00463.x.","journal-title":"Anaesthesia"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-14-232\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-232","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T14:26:04Z","timestamp":1646922364000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-14-232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,25]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["654"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-14-232","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,25]]},"article-number":"232"}}